Kingsview Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Sell
3,355
-593
-15% -$52K ﹤0.01% 1210
2026
Q1
$357K Buy
3,948
+87
+2% +$7.98K ﹤0.01% 1007
2025
Q4
$347K Sell
3,861
-520
-12% -$49.3K 0.01% 972
2025
Q3
$432K Buy
4,381
+2,061
+89% +$204K 0.01% 847
2025
Q2
$212K Sell
2,320
-23
-1% -$2.22K ﹤0.01% 1085
2025
Q1
$265K Sell
2,343
-235
-9% -$25.1K 0.01% 935
2024
Q4
$272K Sell
2,578
-1,094
-30% -$117K 0.01% 946
2024
Q3
$396K Sell
3,672
-82
-2% -$8.95K 0.01% 785
2024
Q2
$407K Buy
3,754
+529
+16% +$62.4K 0.01% 747
2024
Q1
$426K Buy
3,225
+590
+22% +$73.7K 0.01% 709
2023
Q4
$321K Sell
2,635
-1,309
-33% -$146K 0.01% 741
2023
Q3
$443K Sell
3,944
-128
-3% -$16.3K 0.02% 651
2023
Q2
$593K Buy
4,072
+253
+7% +$34.4K 0.02% 550
2023
Q1
$493K Sell
3,819
-919
-19% -$115K 0.02% 579
2022
Q4
$604K Buy
4,738
+2,615
+123% +$303K 0.03% 462
2022
Q3
$222K Buy
+2,123
New +$233K 0.01% 728
2021
Q2
Sell
-5,042
Closed -$783K 1030
2021
Q1
$783K Buy
+5,042
New +$781K 0.04% 398

Other funds holding ZBH

Kingsview Wealth Management's ZBH Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Zimmer Biomet (ZBH) stake by 15% in Q2 2026, selling an estimated $52K and leaving 3,355 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Kingsview Wealth Management first reported a position in ZBH in Q1 2021 and has held it in 17 quarters since. The position peaked at $783K in Q1 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Kingsview Wealth Management held 3,355 shares of Zimmer Biomet worth $289K as of Q2 2026.
  • Kingsview Wealth Management sold 593 Zimmer Biomet shares in Q2 2026, an estimated $52K.
  • Zimmer Biomet made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #1210 holding.
  • Kingsview Wealth Management first reported a position in Zimmer Biomet in Q1 2021 and has held it in 17 quarters since.
  • Kingsview Wealth Management's Zimmer Biomet position peaked at $783K in Q1 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.